Impact of Patisiran, an RNAi Therapeutic, on Orthostatic Intolerance in Patients with Hereditary Transthyretin-Mediated Amyloidosis (766)
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
10.1212/wnl.94.15_supplement.766